Results 121 to 130 of about 778,750 (285)
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud +14 more
wiley +1 more source
Gestational diabetes in multifetal versus singleton pregnancies: A multicenter cohort study
Gestational diabetes in multifetal pregnancies was associated with increased maternal morbidity but less adverse neonatal and long‐term offspring outcomes than in singleton pregnancies, suggesting that current diagnostic thresholds derived from singleton gestations may not fully reflect the unique metabolic and clinical characteristics of multifetal ...
Rinat Gabbay‐Benziv +8 more
wiley +1 more source
Risk factors for glucose intolerance in active acromegaly
In the present retrospective study we determined the frequency of glucose intolerance in active untreated acromegaly, and searched for risk factors possibly supporting the emergence of the diabetic condition. Among 43 patients, 8 (19%; 95% CI: 8-33%) had
Kreze A., Kreze-Spirova E., Mikulecky M.
doaj
Strength training during pregnancy safely improves maternal well‐being, increases physical activity, and reduces pregnancy symptoms, with a promising trend toward lower gestational diabetes. Abstract Introduction Evidence suggests that physical exercise may help prevent gestational diabetes mellitus, although available clinical trials are limited by ...
Teresa E. Santa Cruz +3 more
wiley +1 more source
DESTINE 2.0 decision flowchart: stage‐based assessment and management of driveline exit‐site disorders. The flowchart provides a simplified decision‐support tool for the stage‐based evaluation and management of driveline exit‐site disorders in LVAD patients, intended as a practical complement to the staging pyramid (Figre 2) and the detailed staging ...
Alexander M. Bernhardt +7 more
wiley +1 more source
Abstract Gastric inhibitory polypeptide (GIP)/Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are increasingly prescribed for the management of obesity and type 2 diabetes, yet research pertinent to their effects on muscle health is limited. Considering the central role of muscle strength as a sarcopenia component, this article summarizes emerging ...
Konstantinos Prokopidis
wiley +1 more source
Cortisol Metabolism and Glucose Intolerance [PDF]
Kerstens, MN, Dullaart, RPF
openaire +2 more sources
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Gestational Glucose Intolerance and the Risk of Hypertensive Disorders of Pregnancy. [PDF]
Maya J +9 more
europepmc +1 more source
A comprehensive review of cancer‐induced cardiac wasting
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena +5 more
wiley +1 more source

